(Q35580630)

9 August 2017

1 reference

title

Sildenafil in patients with cardiovascular disease (English)

1 reference

Cardiology and cardiovascular medicine

9 August 2017

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(02)03368-4

31 March 2024

author name string

Ralph G. Brindis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14609621

31 March 2024

Robert A. Kloner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14609621

31 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

9 August 2017

6 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14609621

full work available at URL

31 March 2024

https://api.elsevier.com/content/article/PII:S0002914902033684?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(02)03368-4

https://api.elsevier.com/content/article/PII:S0002914902033684?httpAccept=text/plain

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(02)03368-4

American Journal of Cardiology

31 March 2024

published in

1 reference

9 August 2017

92

1 reference

9 August 2017

26M-36M

1 reference

9 August 2017

9A

1 reference

Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Atherosclerosis: risk factors and the vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Does severity of ischemic coronary disease correlate with erectile function?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Effects of sildenafil citrate on human hemodynamics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Hemodynamic effects of sildenafil in men with severe coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Overall cardiovascular profile of sildenafil citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Cardiovascular risk and sildenafil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903368-4

Oxidative stress and cardiovascular disease

7 January 2021

series ordinal

2

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(02)03368-4

31 March 2024

Identifiers

1 reference

9 August 2017

1 reference